This article is taken from the monthly magazine Sciences et Avenir n°946, dated December 2025.
While research into Parkinson's disease is progressing rapidly, thanks to new treatments that improve patients' quality of life, they only address the symptoms without truly slowing down the neurodegeneration that causes the disease. “Finding a treatment that truly protects neurons is the holy grail of neuroscience.” “,” says Professor John Mitrofanis, a specialist in neurodegenerative diseases at Clinatec (Grenoble) and the University of Sydney (Australia). And with his team, this Australian researcher may have just found this holy grail: a treatment that promises to increase the survival of neurons and slow the progression of the disease: light.
English 
French